IO Biotech
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of IO Biotech generated cash of -$71,737,000, which is less than the previous year. Cash used in financing activities reached the amount of $71,860,000 last year. Net change in cash is therefore $603,000.
Cash Flow
| 2019 | -8.89M | 0 | 9.01M |
|---|---|---|---|
| 2020 | -9.95M | 0 | 5.10M |
| 2021 | -40.64M | -153K | 252.95M |
| 2022 | -59.72M | -690K | 0 |
| 2023 | -71.73M | -323K | 71.86M |
IOBT Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 142.85M | 211.79M | 3.40M | 7.84M | 7.97M |
Operating activities | |||||
Net income | -86.08M | -71.45M | -67.87M | -12.04M | -10.74M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 756K | 540K | 2K | 0 | 0 |
Stock-based compensation expense | 8.05M | 7.04M | 1.79M | 64K | 131K |
| Deferred income tax benefit | 8.05M | 7.04M | 1.79M | 64K | 131K |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -126K | 77K | 3.40M | -475K | 103K |
Cash generated by operating activities | -71.73M | -59.72M | -40.64M | -9.95M | -8.89M |
Investing activities | |||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -323K | -690K | -153K | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -323K | -690K | -153K | 0 | 0 |
Financing activities | |||||
Common Stock Issued | 75.05M | 0 | 115.11M | 5.10M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 71.86M | 0 | 252.95M | 5.10M | 9.01M |
Net Change In Cash | 603K | -68.94M | 208.39M | -4.44M | -125K |
Cash at end of period | 143.46M | 142.85M | 211.79M | 3.40M | 7.84M |
| Data source | Data source | Data source |